Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.1 (
protein kinase
)
81,284
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Glycogen synthase kinase was isolated from rat skeletal muscle. This kinase, which is cyclic nucleotide-independent and calcium-independent, was separated from phosphorylase kinase,
cyclic AMP-dependent protein kinase
and phosvitin kinase by phosphocellulose chromatography. Gel filtration on Sephadex G-100 resolved the
glycogen synthase kinase
into two fractions with apparent molecular weights of 68 000 (peak I) and 52 000 (peak II). This step also separated
glycogen synthase kinase
from the catalytic subunit of the
cyclic AMP-dependent protein kinase
, which had an apparent molecular weight of 39 000. Peak II
glycogen synthase kinase
activity was not affected by the addition of calcium, EGTA or a number of cyclic nucleotides. In addition to ATP, dATP would serve as the phosphate donor. Other trinucleotides tested were either poor or ineffective substrates. Activity was about 5-fold greater with Mg2+ than with Mn2+. Glycogen stimulated activity about 25%. Modifications of the methods of Soderling et al. ((1970) J. Biol. Chem. 245, 6317--6328) and Nimmo et al. ((1976) Eur. J. Biochem. 68, 21--30) were developed for purification of glycogen synthease (UDPglucose:glycogen 4-alpha
D-glucosyltransferase
, EC 2.4.1.11) to specific activity of 35 units/mg of protein. Using this preparation of glycogen synthase as substrate, the phosphorylation and inactivation catalyzed by
glycogen synthase kinase
was compared to that catalyzed by
cyclic AMP-dependent protein kinase
or phosphorylase kinase. Each of the kinases had different specificities for phosphorylation sites on glycogen synthase.
...
PMID:Isolation and characterization of cyclic AMP-independent glycogen synthase kinase from rat skeletal muscle. 625 90